PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China.\', \'Jin Yin-tan Hospital, Wuhan, Hubei, China.\', \'Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.\', \'Wuhan Lung Hospital, Wuhan, China.\', \'Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.\', \'Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.\', \'Wuhan Third Hospital, Wuhan, China.\', \'Renmin Hospital of Wuhan University, Wuhan, China.\', \'Zhongnan Hospital of Wuhan University, Wuhan, China.\', \'Wuhan Fourth Hospital, Wuhan, China.\', \'The Central Hospital of Wuhan, Wuhan, China.\', \'Wuhan First Hospital, Wuhan, China.\', \'Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.\', \'Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China.\', \'Tsinghua University School of Medicine, Beijing, China.\', \'Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Beijing University of Chinese Medicine, Beijing, China.\', \'Tigermed Consulting, Hangzhou, China.\', \'Teddy Clinical Research Laboratory, Shanghai, China.\', \'Hangzhou DI\'AN Medical Laboratory, Hangzhou, China.\', \'Lancaster University, Lancaster, UK; University of Cambridge, Cambridge, UK.\', \'University of Virginia School of Medicine, Charlottesville, VA, USA.\', \'International Severe Acute Respiratory and Emerging Infection Consortium, University of Oxford, Oxford, UK.\', \'Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Department of Respiratory Medicine, Capital Medical University, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijiing, China. Electronic address: caobin_ben@163.com.\', \'Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China; Institute of Respiratory Medicine, Chinese Academy of Medical Science, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, Beijiing, China; Peking Union Medical College, Beijing, China. Electronic address: wangchen@pumc.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0140-6736(20)31022-910.1016/S0140-6736(20)31022-9
?:doi
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32423584
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all